|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net income | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||
| Change in fair value of derivative warrant liabilities | ||||
| Offering costs—derivative warrant liabilities | ||||
| Income from investments held in Trust Account | ||||
| General and administrative expenses paid by related party under promissory note | ||||
| Change in fair value of backstop agreement liability | ||||
| Issuance of Backstop Agreement | ||||
| Income from cash and investments held in Trust Account | ||||
| Changes in operating assets and liabilities: | ||||
| Due to Continental | ||||
| Prepaid expenses | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Net cash used in operating activities | ||||
| Cash Flows from Investing Activities: | ||||
| Erroneous deposit into Trust Account | ||||
| Cash deposited in Trust Account | ||||
| Cash withdrawn for redemptions | ||||
| Net cash provided by investing activities | ||||
| Cash Flows from Financing Activities: | ||||
| Repayment of note payable to related party | ||||
| Proceeds received from promissory note—related party | ||||
| Proceeds received from initial public offering, gross | ||||
| Proceeds received from private placement | ||||
| Redemption of Public Shares | ||||
| Offering costs paid | ||||
| Net cash used in financing activities | ||||
| Cash - beginning of the period | ||||
| Cash - end of the period | ||||
| Net change in cash | ||||
| Cash—beginning of the year | ||||
| Cash—end of the year | ||||
| Offering costs included in accrued expenses | ||||
| Offering costs paid by related party under promissory note | ||||
| Deferred underwriting commissions | ||||
Loading...
